Targeting the $5 BILLION Soft Tissue Repair Market

Chitogenx is in the regulatory lead for regenerative products + signs MOU with major Medical Institute

Free
Message: SmallCap 60: Ortho Regenerative Tech. (ORTH: CSE) (ORTIF: OTCQB) Shareholders and Insiders Continue Support With Sizable Investment

SmallCap 60: Ortho Regenerative Tech. (ORTH: CSE) (ORTIF: OTCQB) Shareholders and Insiders Continue Support With Sizable Investment

posted on Apr 19, 2022 04:10PM

Share
New Message
Please login to post a reply